nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP3A5—prostate cancer	0.0894	0.266	CbGaD
Amiodarone—CYP2A6—prostate cancer	0.0865	0.257	CbGaD
Amiodarone—CYP2C19—prostate cancer	0.0609	0.181	CbGaD
Amiodarone—CYP1A1—prostate cancer	0.0606	0.18	CbGaD
Amiodarone—CYP3A4—prostate cancer	0.0387	0.115	CbGaD
Amiodarone—CYP1A1—Flutamide—prostate cancer	0.022	0.0545	CbGbCtD
Amiodarone—CYP1A1—Estrone—prostate cancer	0.0159	0.0394	CbGbCtD
Amiodarone—CYP2C8—Nilutamide—prostate cancer	0.0153	0.038	CbGbCtD
Amiodarone—CYP3A5—Flutamide—prostate cancer	0.0132	0.0327	CbGbCtD
Amiodarone—CYP2C19—Bicalutamide—prostate cancer	0.0129	0.0319	CbGbCtD
Amiodarone—CYP2C19—Nilutamide—prostate cancer	0.0129	0.0319	CbGbCtD
Amiodarone—CYP2C8—Abiraterone—prostate cancer	0.0127	0.0315	CbGbCtD
Amiodarone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0118	0.0293	CbGbCtD
Amiodarone—CYP2C9—Nilutamide—prostate cancer	0.0107	0.0265	CbGbCtD
Amiodarone—CYP2C9—Bicalutamide—prostate cancer	0.0107	0.0265	CbGbCtD
Amiodarone—CYP2C19—Flutamide—prostate cancer	0.0107	0.0264	CbGbCtD
Amiodarone—CYP1A2—Flutamide—prostate cancer	0.00984	0.0244	CbGbCtD
Amiodarone—CYP2D6—Bicalutamide—prostate cancer	0.00979	0.0242	CbGbCtD
Amiodarone—CYP3A5—Cabazitaxel—prostate cancer	0.00978	0.0242	CbGbCtD
Amiodarone—ABCB1—Estramustine—prostate cancer	0.00966	0.0239	CbGbCtD
Amiodarone—CYP3A5—Estrone—prostate cancer	0.00956	0.0237	CbGbCtD
Amiodarone—CYP2C8—Cabazitaxel—prostate cancer	0.00941	0.0233	CbGbCtD
Amiodarone—CYP1A1—Estradiol—prostate cancer	0.00915	0.0226	CbGbCtD
Amiodarone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0082	0.0203	CbGbCtD
Amiodarone—CYP2D6—Abiraterone—prostate cancer	0.00811	0.0201	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00732	0.0181	CbGbCtD
Amiodarone—CYP3A7—Estradiol—prostate cancer	0.00732	0.0181	CbGbCtD
Amiodarone—CYP1A2—Estrone—prostate cancer	0.00712	0.0176	CbGbCtD
Amiodarone—CYP2C9—Estrone—prostate cancer	0.00641	0.0159	CbGbCtD
Amiodarone—ABCB1—Cabazitaxel—prostate cancer	0.00637	0.0158	CbGbCtD
Amiodarone—CYP3A4—Bicalutamide—prostate cancer	0.00622	0.0154	CbGbCtD
Amiodarone—ABCB1—Estrone—prostate cancer	0.00622	0.0154	CbGbCtD
Amiodarone—CYP3A4—Estramustine—prostate cancer	0.00579	0.0143	CbGbCtD
Amiodarone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00555	0.0137	CbGbCtD
Amiodarone—CYP3A5—Estradiol—prostate cancer	0.00549	0.0136	CbGbCtD
Amiodarone—CYP2C8—Estradiol—prostate cancer	0.00528	0.0131	CbGbCtD
Amiodarone—CYP3A4—Abiraterone—prostate cancer	0.00516	0.0128	CbGbCtD
Amiodarone—CYP3A4—Flutamide—prostate cancer	0.00516	0.0128	CbGbCtD
Amiodarone—CYP2C9—Capecitabine—prostate cancer	0.00486	0.012	CbGbCtD
Amiodarone—CYP1A2—Conjugated Estrogens—prostate cancer	0.00466	0.0115	CbGbCtD
Amiodarone—CYP2C19—Estradiol—prostate cancer	0.00443	0.011	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—prostate cancer	0.00437	0.0108	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00437	0.0108	CbGbCtD
Amiodarone—CYP1A2—Estradiol—prostate cancer	0.00409	0.0101	CbGbCtD
Amiodarone—ABCB1—Conjugated Estrogens—prostate cancer	0.00407	0.0101	CbGbCtD
Amiodarone—CYP3A4—Cabazitaxel—prostate cancer	0.00382	0.00944	CbGbCtD
Amiodarone—CYP2C19—Prednisone—prostate cancer	0.00381	0.00943	CbGbCtD
Amiodarone—CYP3A4—Estrone—prostate cancer	0.00373	0.00923	CbGbCtD
Amiodarone—ABCB1—Mitoxantrone—prostate cancer	0.0037	0.00916	CbGbCtD
Amiodarone—CYP2C9—Estradiol—prostate cancer	0.00368	0.00911	CbGbCtD
Amiodarone—CYP3A5—Etoposide—prostate cancer	0.00359	0.00887	CbGbCtD
Amiodarone—ABCB1—Estradiol—prostate cancer	0.00357	0.00884	CbGbCtD
Amiodarone—CYP2C8—Etoposide—prostate cancer	0.00345	0.00853	CbGbCtD
Amiodarone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00332	0.00822	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—prostate cancer	0.00328	0.00812	CbGbCtD
Amiodarone—ABCB1—Prednisone—prostate cancer	0.00307	0.00761	CbGbCtD
Amiodarone—CYP1A2—Etoposide—prostate cancer	0.00267	0.0066	CbGbCtD
Amiodarone—Lucanthone—APEX1—prostate cancer	0.00264	0.797	CrCbGaD
Amiodarone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00244	0.00604	CbGbCtD
Amiodarone—ABCB1—Etoposide—prostate cancer	0.00233	0.00577	CbGbCtD
Amiodarone—CYP3A4—Mitoxantrone—prostate cancer	0.00222	0.00549	CbGbCtD
Amiodarone—CYP3A4—Estradiol—prostate cancer	0.00214	0.0053	CbGbCtD
Amiodarone—ABCB1—Docetaxel—prostate cancer	0.00214	0.00528	CbGbCtD
Amiodarone—CYP3A4—Prednisone—prostate cancer	0.00184	0.00456	CbGbCtD
Amiodarone—CYP2C19—urine—prostate cancer	0.00159	0.0539	CbGeAlD
Amiodarone—ABCB1—Doxorubicin—prostate cancer	0.00159	0.00394	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—prostate cancer	0.0015	0.00371	CbGbCtD
Amiodarone—THRB—prostate gland—prostate cancer	0.0015	0.0507	CbGeAlD
Amiodarone—THRA—prostate gland—prostate cancer	0.0015	0.0507	CbGeAlD
Amiodarone—CYP3A4—Etoposide—prostate cancer	0.0014	0.00346	CbGbCtD
Amiodarone—CYP1A2—urine—prostate cancer	0.0013	0.044	CbGeAlD
Amiodarone—CYP3A4—Docetaxel—prostate cancer	0.00128	0.00317	CbGbCtD
Amiodarone—CYP2C9—urine—prostate cancer	0.00124	0.0418	CbGeAlD
Amiodarone—CACNA1H—prostate gland—prostate cancer	0.0012	0.0407	CbGeAlD
Amiodarone—THRA—renal system—prostate cancer	0.00102	0.0345	CbGeAlD
Amiodarone—THRB—renal system—prostate cancer	0.00102	0.0345	CbGeAlD
Amiodarone—CACNA1H—seminal vesicle—prostate cancer	0.00102	0.0344	CbGeAlD
Amiodarone—CYP3A4—Doxorubicin—prostate cancer	0.000954	0.00236	CbGbCtD
Amiodarone—CYP3A4—urine—prostate cancer	0.000943	0.0319	CbGeAlD
Amiodarone—CYP2D6—urine—prostate cancer	0.000927	0.0314	CbGeAlD
Amiodarone—CYP2A6—prostate gland—prostate cancer	0.00089	0.0301	CbGeAlD
Amiodarone—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000763	1	CbGdCrCtD
Amiodarone—CYP2A6—seminal vesicle—prostate cancer	0.000753	0.0254	CbGeAlD
Amiodarone—ADRB1—prostate gland—prostate cancer	0.000715	0.0242	CbGeAlD
Amiodarone—SIGMAR1—prostate gland—prostate cancer	0.000686	0.0232	CbGeAlD
Amiodarone—THRB—testis—prostate cancer	0.00066	0.0223	CbGeAlD
Amiodarone—THRA—testis—prostate cancer	0.00066	0.0223	CbGeAlD
Amiodarone—CACNA2D2—testis—prostate cancer	0.000653	0.0221	CbGeAlD
Amiodarone—Lucanthone—TOP2A—prostate cancer	0.000581	0.175	CrCbGaD
Amiodarone—SIGMAR1—seminal vesicle—prostate cancer	0.00058	0.0196	CbGeAlD
Amiodarone—KCNH2—prostate gland—prostate cancer	0.000546	0.0185	CbGeAlD
Amiodarone—CACNA1H—testis—prostate cancer	0.00053	0.0179	CbGeAlD
Amiodarone—THRA—lymph node—prostate cancer	0.000479	0.0162	CbGeAlD
Amiodarone—THRB—lymph node—prostate cancer	0.000479	0.0162	CbGeAlD
Amiodarone—CACNA2D2—lymph node—prostate cancer	0.000473	0.016	CbGeAlD
Amiodarone—KCNH2—seminal vesicle—prostate cancer	0.000462	0.0156	CbGeAlD
Amiodarone—SIGMAR1—urethra—prostate cancer	0.000459	0.0155	CbGeAlD
Amiodarone—CYP3A5—prostate gland—prostate cancer	0.000451	0.0152	CbGeAlD
Amiodarone—CACNA1H—lymph node—prostate cancer	0.000384	0.013	CbGeAlD
Amiodarone—KCNH2—renal system—prostate cancer	0.000372	0.0126	CbGeAlD
Amiodarone—KCNH2—urethra—prostate cancer	0.000366	0.0124	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—prostate cancer	0.000354	0.012	CbGeAlD
Amiodarone—CYP2C8—renal system—prostate cancer	0.00034	0.0115	CbGeAlD
Amiodarone—CYP1A1—epithelium—prostate cancer	0.000339	0.0115	CbGeAlD
Amiodarone—CYP1A2—renal system—prostate cancer	0.000319	0.0108	CbGeAlD
Amiodarone—CYP1A1—renal system—prostate cancer	0.000314	0.0106	CbGeAlD
Amiodarone—CYP1A1—urethra—prostate cancer	0.000309	0.0104	CbGeAlD
Amiodarone—CYP3A5—renal system—prostate cancer	0.000307	0.0104	CbGeAlD
Amiodarone—SIGMAR1—testis—prostate cancer	0.000302	0.0102	CbGeAlD
Amiodarone—KCNH2—bone marrow—prostate cancer	0.000281	0.00951	CbGeAlD
Amiodarone—KCNH2—testis—prostate cancer	0.000241	0.00813	CbGeAlD
Amiodarone—ABCB1—prostate gland—prostate cancer	0.00024	0.0081	CbGeAlD
Amiodarone—CYP3A4—renal system—prostate cancer	0.000231	0.0078	CbGeAlD
Amiodarone—CYP2D6—renal system—prostate cancer	0.000227	0.00767	CbGeAlD
Amiodarone—CYP2C8—testis—prostate cancer	0.00022	0.00744	CbGeAlD
Amiodarone—SIGMAR1—lymph node—prostate cancer	0.000219	0.00741	CbGeAlD
Amiodarone—ABCB1—seminal vesicle—prostate cancer	0.000203	0.00685	CbGeAlD
Amiodarone—ABCB1—epithelium—prostate cancer	0.000176	0.00595	CbGeAlD
Amiodarone—KCNH2—lymph node—prostate cancer	0.000174	0.00589	CbGeAlD
Amiodarone—ABCB1—renal system—prostate cancer	0.000163	0.00552	CbGeAlD
Amiodarone—ABCB1—urethra—prostate cancer	0.00016	0.00542	CbGeAlD
Amiodarone—CYP1A1—lymph node—prostate cancer	0.000147	0.00498	CbGeAlD
Amiodarone—CYP2D6—testis—prostate cancer	0.000147	0.00496	CbGeAlD
Amiodarone—ABCB1—bone marrow—prostate cancer	0.000123	0.00417	CbGeAlD
Amiodarone—ABCB1—testis—prostate cancer	0.000106	0.00357	CbGeAlD
Amiodarone—Dronedarone—CYP3A4—prostate cancer	9.38e-05	0.0283	CrCbGaD
Amiodarone—ABCB1—lymph node—prostate cancer	7.65e-05	0.00259	CbGeAlD
Amiodarone—Oedema—Docetaxel—prostate cancer	3.21e-05	0.000252	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—prostate cancer	3.2e-05	0.000251	CcSEcCtD
Amiodarone—Discomfort—Capecitabine—prostate cancer	3.2e-05	0.000251	CcSEcCtD
Amiodarone—Vision blurred—Prednisone—prostate cancer	3.19e-05	0.000251	CcSEcCtD
Amiodarone—Infection—Docetaxel—prostate cancer	3.19e-05	0.00025	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—prostate cancer	3.18e-05	0.00025	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—prostate cancer	3.18e-05	0.00025	CcSEcCtD
Amiodarone—Diarrhoea—Mitoxantrone—prostate cancer	3.17e-05	0.000249	CcSEcCtD
Amiodarone—Dry mouth—Capecitabine—prostate cancer	3.17e-05	0.000249	CcSEcCtD
Amiodarone—Vomiting—Estradiol—prostate cancer	3.17e-05	0.000249	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—prostate cancer	3.16e-05	0.000248	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—prostate cancer	3.16e-05	0.000248	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—prostate cancer	3.16e-05	0.000248	CcSEcCtD
Amiodarone—Shock—Docetaxel—prostate cancer	3.15e-05	0.000248	CcSEcCtD
Amiodarone—Ill-defined disorder—Prednisone—prostate cancer	3.14e-05	0.000247	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—prostate cancer	3.14e-05	0.000246	CcSEcCtD
Amiodarone—Rash—Estradiol—prostate cancer	3.14e-05	0.000246	CcSEcCtD
Amiodarone—Dermatitis—Estradiol—prostate cancer	3.14e-05	0.000246	CcSEcCtD
Amiodarone—Confusional state—Capecitabine—prostate cancer	3.13e-05	0.000246	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—prostate cancer	3.13e-05	0.000246	CcSEcCtD
Amiodarone—Headache—Estradiol—prostate cancer	3.12e-05	0.000245	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—prostate cancer	3.11e-05	0.000245	CcSEcCtD
Amiodarone—Agitation—Prednisone—prostate cancer	3.11e-05	0.000244	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.11e-05	0.000244	CcSEcCtD
Amiodarone—Oedema—Capecitabine—prostate cancer	3.1e-05	0.000244	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—prostate cancer	3.1e-05	0.000243	CcSEcCtD
Amiodarone—Angioedema—Prednisone—prostate cancer	3.1e-05	0.000243	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—prostate cancer	3.08e-05	0.000242	CcSEcCtD
Amiodarone—Infection—Capecitabine—prostate cancer	3.08e-05	0.000242	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—prostate cancer	3.08e-05	0.000241	CcSEcCtD
Amiodarone—Urticaria—Etoposide—prostate cancer	3.07e-05	0.000241	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—prostate cancer	3.06e-05	0.00024	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—prostate cancer	3.06e-05	0.00024	CcSEcCtD
Amiodarone—Malaise—Prednisone—prostate cancer	3.06e-05	0.00024	CcSEcCtD
Amiodarone—Shock—Capecitabine—prostate cancer	3.05e-05	0.00024	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—prostate cancer	3.05e-05	0.000239	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—prostate cancer	3.05e-05	0.000239	CcSEcCtD
Amiodarone—Vertigo—Prednisone—prostate cancer	3.04e-05	0.000239	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—prostate cancer	3.04e-05	0.000239	CcSEcCtD
Amiodarone—Thrombocytopenia—Capecitabine—prostate cancer	3.04e-05	0.000239	CcSEcCtD
Amiodarone—Tachycardia—Capecitabine—prostate cancer	3.03e-05	0.000238	CcSEcCtD
Amiodarone—Skin disorder—Capecitabine—prostate cancer	3.02e-05	0.000237	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—prostate cancer	3.01e-05	0.000236	CcSEcCtD
Amiodarone—Hyperhidrosis—Capecitabine—prostate cancer	3e-05	0.000236	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—prostate cancer	3e-05	0.000235	CcSEcCtD
Amiodarone—Anorexia—Capecitabine—prostate cancer	2.96e-05	0.000232	CcSEcCtD
Amiodarone—Nausea—Estradiol—prostate cancer	2.96e-05	0.000232	CcSEcCtD
Amiodarone—Vomiting—Mitoxantrone—prostate cancer	2.95e-05	0.000232	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—prostate cancer	2.93e-05	0.00023	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—prostate cancer	2.93e-05	0.00023	CcSEcCtD
Amiodarone—Rash—Mitoxantrone—prostate cancer	2.92e-05	0.00023	CcSEcCtD
Amiodarone—Dermatitis—Mitoxantrone—prostate cancer	2.92e-05	0.000229	CcSEcCtD
Amiodarone—Headache—Mitoxantrone—prostate cancer	2.91e-05	0.000228	CcSEcCtD
Amiodarone—Hypotension—Capecitabine—prostate cancer	2.9e-05	0.000228	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—prostate cancer	2.9e-05	0.000228	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—prostate cancer	2.88e-05	0.000226	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—prostate cancer	2.88e-05	0.000226	CcSEcCtD
Amiodarone—Anxiety—Prednisone—prostate cancer	2.87e-05	0.000226	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—prostate cancer	2.87e-05	0.000225	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—prostate cancer	2.86e-05	0.000224	CcSEcCtD
Amiodarone—Discomfort—Prednisone—prostate cancer	2.85e-05	0.000224	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—prostate cancer	2.84e-05	0.000223	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—prostate cancer	2.84e-05	0.000223	CcSEcCtD
Amiodarone—Flushing—Epirubicin—prostate cancer	2.83e-05	0.000222	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—prostate cancer	2.82e-05	0.000222	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—prostate cancer	2.82e-05	0.000221	CcSEcCtD
Amiodarone—Insomnia—Capecitabine—prostate cancer	2.81e-05	0.00022	CcSEcCtD
Amiodarone—Paraesthesia—Capecitabine—prostate cancer	2.79e-05	0.000219	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—prostate cancer	2.79e-05	0.000219	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—prostate cancer	2.77e-05	0.000217	CcSEcCtD
Amiodarone—Asthenia—Etoposide—prostate cancer	2.77e-05	0.000217	CcSEcCtD
Amiodarone—Dyspnoea—Capecitabine—prostate cancer	2.77e-05	0.000217	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisone—prostate cancer	2.77e-05	0.000217	CcSEcCtD
Amiodarone—Oedema—Prednisone—prostate cancer	2.77e-05	0.000217	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—prostate cancer	2.76e-05	0.000217	CcSEcCtD
Amiodarone—Nausea—Mitoxantrone—prostate cancer	2.76e-05	0.000216	CcSEcCtD
Amiodarone—Infection—Prednisone—prostate cancer	2.75e-05	0.000216	CcSEcCtD
Amiodarone—Pain—Docetaxel—prostate cancer	2.74e-05	0.000215	CcSEcCtD
Amiodarone—Constipation—Docetaxel—prostate cancer	2.74e-05	0.000215	CcSEcCtD
Amiodarone—Dyspepsia—Capecitabine—prostate cancer	2.73e-05	0.000215	CcSEcCtD
Amiodarone—Pruritus—Etoposide—prostate cancer	2.73e-05	0.000214	CcSEcCtD
Amiodarone—Shock—Prednisone—prostate cancer	2.72e-05	0.000214	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—prostate cancer	2.72e-05	0.000214	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—prostate cancer	2.71e-05	0.000213	CcSEcCtD
Amiodarone—Tachycardia—Prednisone—prostate cancer	2.7e-05	0.000212	CcSEcCtD
Amiodarone—Decreased appetite—Capecitabine—prostate cancer	2.7e-05	0.000212	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—prostate cancer	2.69e-05	0.000211	CcSEcCtD
Amiodarone—Skin disorder—Prednisone—prostate cancer	2.69e-05	0.000211	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Capecitabine—prostate cancer	2.68e-05	0.00021	CcSEcCtD
Amiodarone—Fatigue—Capecitabine—prostate cancer	2.68e-05	0.00021	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisone—prostate cancer	2.67e-05	0.00021	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—prostate cancer	2.66e-05	0.000209	CcSEcCtD
Amiodarone—Pain—Capecitabine—prostate cancer	2.65e-05	0.000208	CcSEcCtD
Amiodarone—Constipation—Capecitabine—prostate cancer	2.65e-05	0.000208	CcSEcCtD
Amiodarone—Erythema—Epirubicin—prostate cancer	2.65e-05	0.000208	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—prostate cancer	2.64e-05	0.000207	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—prostate cancer	2.64e-05	0.000207	CcSEcCtD
Amiodarone—Anorexia—Prednisone—prostate cancer	2.64e-05	0.000207	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—prostate cancer	2.63e-05	0.000206	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—prostate cancer	2.62e-05	0.000206	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—prostate cancer	2.61e-05	0.000205	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—prostate cancer	2.6e-05	0.000204	CcSEcCtD
Amiodarone—Back pain—Epirubicin—prostate cancer	2.56e-05	0.000201	CcSEcCtD
Amiodarone—Feeling abnormal—Capecitabine—prostate cancer	2.56e-05	0.000201	CcSEcCtD
Amiodarone—Dizziness—Etoposide—prostate cancer	2.55e-05	0.0002	CcSEcCtD
Amiodarone—Gastrointestinal pain—Capecitabine—prostate cancer	2.54e-05	0.000199	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—prostate cancer	2.53e-05	0.000199	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—prostate cancer	2.53e-05	0.000199	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—prostate cancer	2.52e-05	0.000198	CcSEcCtD
Amiodarone—Insomnia—Prednisone—prostate cancer	2.5e-05	0.000196	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—prostate cancer	2.5e-05	0.000196	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—prostate cancer	2.49e-05	0.000195	CcSEcCtD
Amiodarone—Paraesthesia—Prednisone—prostate cancer	2.48e-05	0.000195	CcSEcCtD
Amiodarone—Urticaria—Capecitabine—prostate cancer	2.47e-05	0.000194	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—prostate cancer	2.46e-05	0.000193	CcSEcCtD
Amiodarone—Abdominal pain—Capecitabine—prostate cancer	2.45e-05	0.000193	CcSEcCtD
Amiodarone—Body temperature increased—Capecitabine—prostate cancer	2.45e-05	0.000193	CcSEcCtD
Amiodarone—Vomiting—Etoposide—prostate cancer	2.45e-05	0.000193	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—prostate cancer	2.45e-05	0.000193	CcSEcCtD
Amiodarone—Agitation—Epirubicin—prostate cancer	2.44e-05	0.000191	CcSEcCtD
Amiodarone—Dyspepsia—Prednisone—prostate cancer	2.43e-05	0.000191	CcSEcCtD
Amiodarone—Rash—Etoposide—prostate cancer	2.43e-05	0.000191	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—prostate cancer	2.43e-05	0.000191	CcSEcCtD
Amiodarone—Headache—Etoposide—prostate cancer	2.42e-05	0.00019	CcSEcCtD
Amiodarone—Decreased appetite—Prednisone—prostate cancer	2.4e-05	0.000189	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—prostate cancer	2.4e-05	0.000189	CcSEcCtD
Amiodarone—Malaise—Epirubicin—prostate cancer	2.39e-05	0.000188	CcSEcCtD
Amiodarone—Fatigue—Prednisone—prostate cancer	2.38e-05	0.000187	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—prostate cancer	2.38e-05	0.000187	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—prostate cancer	2.37e-05	0.000186	CcSEcCtD
Amiodarone—Constipation—Prednisone—prostate cancer	2.36e-05	0.000186	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—prostate cancer	2.36e-05	0.000185	CcSEcCtD
Amiodarone—Cough—Epirubicin—prostate cancer	2.31e-05	0.000182	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—prostate cancer	2.31e-05	0.000181	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—prostate cancer	2.3e-05	0.000181	CcSEcCtD
Amiodarone—Nausea—Etoposide—prostate cancer	2.29e-05	0.00018	CcSEcCtD
Amiodarone—Hypersensitivity—Capecitabine—prostate cancer	2.29e-05	0.00018	CcSEcCtD
Amiodarone—Feeling abnormal—Prednisone—prostate cancer	2.28e-05	0.000179	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—prostate cancer	2.28e-05	0.000179	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—prostate cancer	2.27e-05	0.000178	CcSEcCtD
Amiodarone—Gastrointestinal pain—Prednisone—prostate cancer	2.26e-05	0.000178	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—prostate cancer	2.25e-05	0.000177	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—prostate cancer	2.25e-05	0.000177	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—prostate cancer	2.23e-05	0.000175	CcSEcCtD
Amiodarone—Asthenia—Capecitabine—prostate cancer	2.23e-05	0.000175	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—prostate cancer	2.21e-05	0.000174	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—prostate cancer	2.21e-05	0.000173	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—prostate cancer	2.2e-05	0.000173	CcSEcCtD
Amiodarone—Urticaria—Prednisone—prostate cancer	2.2e-05	0.000172	CcSEcCtD
Amiodarone—Pruritus—Capecitabine—prostate cancer	2.2e-05	0.000172	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—prostate cancer	2.19e-05	0.000172	CcSEcCtD
Amiodarone—Abdominal pain—Prednisone—prostate cancer	2.19e-05	0.000172	CcSEcCtD
Amiodarone—Body temperature increased—Prednisone—prostate cancer	2.19e-05	0.000172	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—prostate cancer	2.18e-05	0.000171	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—prostate cancer	2.16e-05	0.00017	CcSEcCtD
Amiodarone—Oedema—Epirubicin—prostate cancer	2.16e-05	0.00017	CcSEcCtD
Amiodarone—Infection—Epirubicin—prostate cancer	2.15e-05	0.000169	CcSEcCtD
Amiodarone—Cough—Doxorubicin—prostate cancer	2.14e-05	0.000168	CcSEcCtD
Amiodarone—Shock—Epirubicin—prostate cancer	2.13e-05	0.000167	CcSEcCtD
Amiodarone—Diarrhoea—Capecitabine—prostate cancer	2.12e-05	0.000167	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—prostate cancer	2.12e-05	0.000166	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—prostate cancer	2.12e-05	0.000166	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—prostate cancer	2.11e-05	0.000166	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—prostate cancer	2.1e-05	0.000165	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—prostate cancer	2.09e-05	0.000164	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—prostate cancer	2.08e-05	0.000163	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—prostate cancer	2.06e-05	0.000162	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—prostate cancer	2.06e-05	0.000162	CcSEcCtD
Amiodarone—Dizziness—Capecitabine—prostate cancer	2.05e-05	0.000161	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—prostate cancer	2.04e-05	0.00016	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—prostate cancer	2.04e-05	0.00016	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisone—prostate cancer	2.04e-05	0.00016	CcSEcCtD
Amiodarone—Rash—Docetaxel—prostate cancer	2.02e-05	0.000159	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—prostate cancer	2.02e-05	0.000159	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—prostate cancer	2.02e-05	0.000159	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—prostate cancer	2.02e-05	0.000158	CcSEcCtD
Amiodarone—Headache—Docetaxel—prostate cancer	2.01e-05	0.000158	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—prostate cancer	2e-05	0.000157	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—prostate cancer	2e-05	0.000157	CcSEcCtD
Amiodarone—Infection—Doxorubicin—prostate cancer	1.99e-05	0.000156	CcSEcCtD
Amiodarone—Asthenia—Prednisone—prostate cancer	1.98e-05	0.000156	CcSEcCtD
Amiodarone—Vomiting—Capecitabine—prostate cancer	1.97e-05	0.000155	CcSEcCtD
Amiodarone—Shock—Doxorubicin—prostate cancer	1.97e-05	0.000155	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—prostate cancer	1.96e-05	0.000154	CcSEcCtD
Amiodarone—Rash—Capecitabine—prostate cancer	1.96e-05	0.000154	CcSEcCtD
Amiodarone—Pruritus—Prednisone—prostate cancer	1.96e-05	0.000154	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—prostate cancer	1.96e-05	0.000154	CcSEcCtD
Amiodarone—Dermatitis—Capecitabine—prostate cancer	1.96e-05	0.000154	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—prostate cancer	1.95e-05	0.000153	CcSEcCtD
Amiodarone—Headache—Capecitabine—prostate cancer	1.94e-05	0.000153	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—prostate cancer	1.94e-05	0.000153	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—prostate cancer	1.94e-05	0.000152	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—prostate cancer	1.93e-05	0.000152	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—prostate cancer	1.93e-05	0.000151	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—prostate cancer	1.91e-05	0.00015	CcSEcCtD
Amiodarone—Nausea—Docetaxel—prostate cancer	1.9e-05	0.00015	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—prostate cancer	1.9e-05	0.000149	CcSEcCtD
Amiodarone—Diarrhoea—Prednisone—prostate cancer	1.89e-05	0.000149	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—prostate cancer	1.88e-05	0.000148	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—prostate cancer	1.87e-05	0.000147	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—prostate cancer	1.87e-05	0.000147	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—prostate cancer	1.86e-05	0.000146	CcSEcCtD
Amiodarone—Pain—Epirubicin—prostate cancer	1.85e-05	0.000145	CcSEcCtD
Amiodarone—Constipation—Epirubicin—prostate cancer	1.85e-05	0.000145	CcSEcCtD
Amiodarone—Nausea—Capecitabine—prostate cancer	1.84e-05	0.000145	CcSEcCtD
Amiodarone—Dizziness—Prednisone—prostate cancer	1.83e-05	0.000144	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—prostate cancer	1.81e-05	0.000142	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—prostate cancer	1.8e-05	0.000141	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—prostate cancer	1.78e-05	0.00014	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—prostate cancer	1.78e-05	0.00014	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—prostate cancer	1.77e-05	0.000139	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—prostate cancer	1.76e-05	0.000138	CcSEcCtD
Amiodarone—Vomiting—Prednisone—prostate cancer	1.76e-05	0.000138	CcSEcCtD
Amiodarone—Rash—Prednisone—prostate cancer	1.74e-05	0.000137	CcSEcCtD
Amiodarone—Dermatitis—Prednisone—prostate cancer	1.74e-05	0.000137	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—prostate cancer	1.74e-05	0.000137	CcSEcCtD
Amiodarone—Headache—Prednisone—prostate cancer	1.73e-05	0.000136	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.73e-05	0.000136	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—prostate cancer	1.73e-05	0.000135	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—prostate cancer	1.72e-05	0.000135	CcSEcCtD
Amiodarone—Pain—Doxorubicin—prostate cancer	1.71e-05	0.000134	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—prostate cancer	1.71e-05	0.000134	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—prostate cancer	1.71e-05	0.000134	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—prostate cancer	1.71e-05	0.000134	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—prostate cancer	1.65e-05	0.000129	CcSEcCtD
Amiodarone—Nausea—Prednisone—prostate cancer	1.64e-05	0.000129	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.64e-05	0.000128	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—prostate cancer	1.59e-05	0.000125	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—prostate cancer	1.59e-05	0.000125	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—prostate cancer	1.58e-05	0.000124	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—prostate cancer	1.58e-05	0.000124	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—prostate cancer	1.55e-05	0.000122	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—prostate cancer	1.53e-05	0.00012	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—prostate cancer	1.48e-05	0.000116	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—prostate cancer	1.47e-05	0.000116	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—prostate cancer	1.44e-05	0.000113	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—prostate cancer	1.43e-05	0.000112	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—prostate cancer	1.42e-05	0.000111	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—prostate cancer	1.38e-05	0.000108	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—prostate cancer	1.37e-05	0.000108	CcSEcCtD
Amiodarone—Rash—Epirubicin—prostate cancer	1.36e-05	0.000107	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—prostate cancer	1.36e-05	0.000107	CcSEcCtD
Amiodarone—Headache—Epirubicin—prostate cancer	1.35e-05	0.000106	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—prostate cancer	1.32e-05	0.000104	CcSEcCtD
Amiodarone—Nausea—Epirubicin—prostate cancer	1.28e-05	0.000101	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—prostate cancer	1.27e-05	9.99e-05	CcSEcCtD
Amiodarone—Rash—Doxorubicin—prostate cancer	1.26e-05	9.91e-05	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—prostate cancer	1.26e-05	9.9e-05	CcSEcCtD
Amiodarone—Headache—Doxorubicin—prostate cancer	1.25e-05	9.84e-05	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—prostate cancer	1.19e-05	9.33e-05	CcSEcCtD
Amiodarone—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.31e-06	1.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	1.3e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.3e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NQO1—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—prostate cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NOS3—prostate cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—prostate cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—COMT—prostate cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—prostate cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TH—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—COMT—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAV1—prostate cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.27e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—prostate cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ITPR1—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—LPL—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGF2—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ITPR1—prostate cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—prostate cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARA—prostate cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOS3—prostate cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—LPL—prostate cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.21e-06	1.23e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ACHE—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GGT1—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JAK2—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.19e-06	1.2e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—prostate cancer	1.18e-06	1.2e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOA1—prostate cancer	1.18e-06	1.2e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.18e-06	1.19e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—prostate cancer	1.18e-06	1.19e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.17e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAV1—prostate cancer	1.16e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—prostate cancer	1.16e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—INS—prostate cancer	1.16e-06	1.17e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—prostate cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—LPL—prostate cancer	1.15e-06	1.16e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—LPL—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.13e-06	1.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RXRA—prostate cancer	1.13e-06	1.14e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—prostate cancer	1.12e-06	1.14e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—prostate cancer	1.12e-06	1.13e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.11e-06	1.13e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.11e-06	1.12e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARA—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—prostate cancer	1.1e-06	1.11e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—INS—prostate cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—prostate cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—COMT—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—prostate cancer	1.08e-06	1.09e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARA—prostate cancer	1.08e-06	1.09e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CREBBP—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ITPR1—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—prostate cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.04e-06	1.05e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAV1—prostate cancer	1.04e-06	1.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—prostate cancer	1.03e-06	1.04e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—prostate cancer	1.03e-06	1.04e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARA—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NOS3—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAV1—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARA—prostate cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—prostate cancer	1e-06	1.02e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—INS—prostate cancer	1e-06	1.02e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NQO1—prostate cancer	9.98e-07	1.01e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—prostate cancer	9.91e-07	1e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.91e-07	1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—prostate cancer	9.88e-07	1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	9.84e-07	9.97e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TH—prostate cancer	9.84e-07	9.97e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—prostate cancer	9.82e-07	9.95e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CREBBP—prostate cancer	9.81e-07	9.95e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—prostate cancer	9.78e-07	9.92e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—LPL—prostate cancer	9.73e-07	9.86e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NOS3—prostate cancer	9.58e-07	9.71e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—prostate cancer	9.58e-07	9.71e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1B1—prostate cancer	9.57e-07	9.7e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAV1—prostate cancer	9.54e-07	9.67e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAV1—prostate cancer	9.46e-07	9.58e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—prostate cancer	9.45e-07	9.57e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1A1—prostate cancer	9.4e-07	9.52e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—prostate cancer	9.36e-07	9.49e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—prostate cancer	9.36e-07	9.49e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—prostate cancer	9.32e-07	9.45e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—prostate cancer	9.3e-07	9.43e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—prostate cancer	9.28e-07	9.4e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GGT1—prostate cancer	9.27e-07	9.39e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—prostate cancer	9.22e-07	9.34e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA1—prostate cancer	9.13e-07	9.25e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—prostate cancer	9.11e-07	9.23e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.03e-07	9.16e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP19A1—prostate cancer	9e-07	9.12e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—INS—prostate cancer	8.94e-07	9.06e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—prostate cancer	8.87e-07	8.99e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—prostate cancer	8.84e-07	8.96e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NOS3—prostate cancer	8.78e-07	8.9e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—prostate cancer	8.78e-07	8.9e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—prostate cancer	8.76e-07	8.88e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—prostate cancer	8.76e-07	8.88e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CREBBP—prostate cancer	8.76e-07	8.88e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—INS—prostate cancer	8.73e-07	8.85e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—prostate cancer	8.69e-07	8.81e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RXRA—prostate cancer	8.68e-07	8.8e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.61e-07	8.73e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARA—prostate cancer	8.59e-07	8.71e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CREBBP—prostate cancer	8.55e-07	8.66e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—COMT—prostate cancer	8.36e-07	8.48e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—prostate cancer	8.32e-07	8.44e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—prostate cancer	8.3e-07	8.42e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—INS—prostate cancer	8.22e-07	8.34e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ITPR1—prostate cancer	8.19e-07	8.3e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—prostate cancer	8.16e-07	8.27e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—INS—prostate cancer	8.15e-07	8.26e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—prostate cancer	8.14e-07	8.25e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—prostate cancer	8.11e-07	8.22e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—prostate cancer	8.1e-07	8.22e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—prostate cancer	8.09e-07	8.2e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAV1—prostate cancer	8.08e-07	8.19e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CREBBP—prostate cancer	8.06e-07	8.16e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—prostate cancer	8.03e-07	8.14e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CREBBP—prostate cancer	7.99e-07	8.09e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—prostate cancer	7.98e-07	8.09e-06	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—prostate cancer	7.9e-07	8e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NOS3—prostate cancer	7.84e-07	7.95e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—prostate cancer	7.74e-07	7.84e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.72e-07	7.82e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—prostate cancer	7.72e-07	7.82e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NOS3—prostate cancer	7.65e-07	7.76e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—prostate cancer	7.65e-07	7.75e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—prostate cancer	7.64e-07	7.75e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—prostate cancer	7.64e-07	7.74e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.57e-07	7.67e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—prostate cancer	7.54e-07	7.64e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LPL—prostate cancer	7.51e-07	7.61e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—prostate cancer	7.36e-07	7.46e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—prostate cancer	7.29e-07	7.39e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A1—prostate cancer	7.25e-07	7.35e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—prostate cancer	7.24e-07	7.34e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—prostate cancer	7.24e-07	7.34e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NOS3—prostate cancer	7.21e-07	7.31e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—prostate cancer	7.19e-07	7.29e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—prostate cancer	7.17e-07	7.27e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NOS3—prostate cancer	7.15e-07	7.25e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—prostate cancer	7.06e-07	7.16e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—prostate cancer	7.01e-07	7.1e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—prostate cancer	7e-07	7.09e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—INS—prostate cancer	6.97e-07	7.06e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	6.93e-07	7.02e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CREBBP—prostate cancer	6.82e-07	6.92e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—prostate cancer	6.76e-07	6.85e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—prostate cancer	6.7e-07	6.79e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—prostate cancer	6.68e-07	6.77e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—prostate cancer	6.66e-07	6.75e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARA—prostate cancer	6.63e-07	6.72e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.6e-07	6.69e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—prostate cancer	6.6e-07	6.69e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—prostate cancer	6.54e-07	6.63e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—prostate cancer	6.47e-07	6.56e-06	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—prostate cancer	6.45e-07	6.54e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—prostate cancer	6.25e-07	6.34e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAV1—prostate cancer	6.24e-07	6.32e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—prostate cancer	6.13e-07	6.22e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NOS3—prostate cancer	6.11e-07	6.19e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—prostate cancer	6.1e-07	6.19e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—prostate cancer	5.96e-07	6.05e-06	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—prostate cancer	5.91e-07	5.99e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—prostate cancer	5.82e-07	5.9e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—prostate cancer	5.75e-07	5.83e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—prostate cancer	5.71e-07	5.78e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—prostate cancer	5.7e-07	5.78e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.68e-07	5.76e-06	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—prostate cancer	5.66e-07	5.74e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—prostate cancer	5.64e-07	5.72e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—prostate cancer	5.59e-07	5.66e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—prostate cancer	5.49e-07	5.56e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—prostate cancer	5.44e-07	5.51e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—prostate cancer	5.39e-07	5.47e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—INS—prostate cancer	5.38e-07	5.45e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CREBBP—prostate cancer	5.27e-07	5.34e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.99e-07	5.06e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.94e-07	5.01e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—prostate cancer	4.87e-07	4.94e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NOS3—prostate cancer	4.72e-07	4.78e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—prostate cancer	4.66e-07	4.73e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—prostate cancer	4.65e-07	4.71e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.41e-07	4.47e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—prostate cancer	4.4e-07	4.46e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.35e-07	4.41e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—prostate cancer	4.31e-07	4.37e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—prostate cancer	4.31e-07	4.37e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.06e-07	4.11e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—prostate cancer	4.04e-07	4.09e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—prostate cancer	4.02e-07	4.08e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—prostate cancer	3.76e-07	3.81e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—prostate cancer	3.6e-07	3.65e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—prostate cancer	3.59e-07	3.64e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—prostate cancer	3.52e-07	3.57e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.44e-07	3.48e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—prostate cancer	3.32e-07	3.36e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—prostate cancer	3.29e-07	3.33e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—prostate cancer	2.81e-07	2.85e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.65e-07	2.69e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—prostate cancer	2.17e-07	2.2e-06	CbGpPWpGaD
